Status:
COMPLETED
The VA Diabetes Trial Follow-up Study (VADT-FS)
Lead Sponsor:
VA Office of Research and Development
Conditions:
Diabetes
Glycemic Control
Eligibility:
All Genders
40+ years
Brief Summary
CSP #465, "Glycemic Control and Complications in Diabetes Mellitus Type 2," was a randomized unblinded clinical trial comparing tight glycemic control to standard glycemic control. Tight glycemic cont...
Detailed Description
Diabetes mellitus is a major health problem in the U.S., especially in the VA population. The majority of diabetics are Type 2, and they are at risk for microvascular (e.g. eye, kidney) and macrovascu...
Eligibility Criteria
Inclusion
- All patients active at the end of VADT will be approached for participation.
Exclusion
- The only exclusion criterion will be failure to achieve consent for continued participation.
Key Trial Info
Start Date :
February 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
1044 Patients enrolled
Trial Details
Trial ID
NCT00756613
Start Date
February 1 2008
End Date
December 31 2017
Last Update
June 19 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix VA Health Care System, Phoenix, AZ
Phoenix, Arizona, United States, 85012
2
Hines VAMC, Hines IL
Hines, Illinois, United States, 60141